ANHEDONIA, DEPRESSION, ANXIETY, AND CRAVING FOR OPIATES IN OPIATE DEPENDENT PATIENTS STABILIZED ON ORAL NALTREXONE OR AN EXTENDED RELEASE NALTREXONE IMPLANT

BACKGROUND: Naltrexone is a μ-opioid receptor antagonist that blocks opioid effects. Craving, depression, anxiety, and anhedonia are common among opioid dependent individuals and concerns have been raised that naltrexone increases them due to blocking endogenous opioids. Here we present data that ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Drug Alcohol Abuse
Main Authors: Krupitsky, Evgeny, Zvartau, Edwin, Blokhina, Elena, Verbitskaya, Elena, Wahlgren, Valentina, Tsoy-Podosenin, Marina, Bushara, Natalia, Burakov, Andrey, Masalov, Dmitry, Romanova, Tatyana, Tyurina, Arina, Palatkin, Vladimir, Yaroslavtseva, Tatyana, Pecoraro, Anna, Woody, George
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156574/
https://ncbi.nlm.nih.gov/pubmed/27436632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2016.1197231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados